Efficacy Study of DeepDDH System in Screening Infants with Developmental Dysplasia of the Hip (DDH)
- Conditions
- Hip Dysplasia, Developmental
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 1976
- Registration Number
- NCT06765525
- Locations
- 🇨🇳
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging
- Conditions
- Bladder Cancer
- First Posted Date
- 2025-01-08
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06763354
- Locations
- 🇨🇳
Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC
- Conditions
- Esophageal Squamous Cell Carcinoma (ESCC)
- Interventions
- Radiation: Neoadjuvant ChemoradiotherapyDrug: neoadjuvant immunotherapyProcedure: SurgeryDrug: adjuvant immunotherapy
- First Posted Date
- 2025-01-07
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06762158
- Locations
- 🇨🇳
Radiation Oncology Department, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Development of AI Model for Renal Tumor Diagnosis Using CT and Lab Tests
- Conditions
- Renal Tumors
- First Posted Date
- 2025-01-07
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 1922
- Registration Number
- NCT06761742
- Locations
- 🇨🇳
Shanghai Jiaotong University School of Medicine, Renji Hospital, Shanghai, Shanghai, China
Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage
- Conditions
- Postpartum HemorrhageSystemic Autoimmune Diseases
- Interventions
- Drug: normal saline
- First Posted Date
- 2024-12-31
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 276
- Registration Number
- NCT06754371
- Locations
- 🇨🇳
Renji Hospital, Shanghai Jiaotong University, School of Medcine, Shanghai, Shanghai, China
Risk Factors for Postpartum Hemorrhage
- Conditions
- Postpartum HemorrhageSystemic Autoimmune Diseases
- First Posted Date
- 2024-12-12
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 1757
- Registration Number
- NCT06730919
- Locations
- 🇨🇳
Renji Hospital, Shanghai Jiaotong University, School of Medcine, Shanghai, Shanghai, China
A Prospective，Single Arm, Multicenter Clinical Study of BTLA Monoclonal Antibody JS004 (B/T Lymphocyte Attenuator Factor Monoclonal Antibody) in Combination With Toripalimab in Patients With Unresectable or Advanced Renal Cell Carcinoma Who Had Failed Previous Immunotherapy
- Conditions
- Unresectable or Advanced Clear Cell Renal Cell Carcinoma That Has Progressed After Previous Immunotherapy
- Interventions
- Drug: JS004（BTLA monoclonal antibody，intravenously）,Toripalimab（ anti-PD-1specific antibody，intravenously)
- First Posted Date
- 2024-12-12
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 31
- Registration Number
- NCT06730932
- Locations
- 🇨🇳
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China, China
Clinical Study on Thymus-Kidney Transplantation From Neonatal Donors for the Induction of Immune Tolerance
- Conditions
- Kidney Transplant
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT06715865
- Locations
- 🇨🇳
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Target-specific immunoPET Imaging of Breast Cancer
- Conditions
- Breast Cancer MetastaticBreast CancerBreast Neoplasms
- Interventions
- Drug: [68Ga]Ga-NOTA-T4Drug: [18F]F-RESCA-T4Drug: [68Ga]Ga-DOTA-H2D3Drug: [18F]F-RESCA-RB14
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06715826
- Locations
- 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China
Target-specific immunoPET Imaging of Digestive System Carcinoma
- Conditions
- MalignancyDigestive CancerDigestive System NeoplasmDigestive System CarcinomaDigestive System CancerLiver CancerStomach CancerColon CancerRectum CancerPancreatic Cancer
- Interventions
- Drug: [68Ga]Ga-DOTA-H2D3Drug: [18F]F-RESCA-RB14Drug: [68Ga]Ga-NOTA-T4Drug: [18F]F-RESCA-T4Drug: [68Ga]Ga-NOTA-G5Drug: [18F]F-RESCA-G5Drug: [68Ga]Ga-NOTA-WWH347Drug: [18F]F-RESCA-WWH347Drug: [68Ga]Ga-NOTA-RND20Drug: [18F]F-RESCA-RND20
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06715839
- Locations
- 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China